ImmunoGenesis

About:

ImmunoGenesis specializes in science-driven immune therapies for tumor treatment.

Website: https://www.immunogenesis.com/

Top Investors: Cancer Prevention and Research Institute of Texas, Texas HALO Fund, Juno Capital, Cancer Focus Fund

Description:

ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.

Total Funding Amount:

$28M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)immunogenesis.com

Founders:

Michael Curran, William Tanner

Number of Employees:

11-50

Last Funding Date:

2023-06-27

IPO Status:

Private

Industries: